BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35319461)

  • 21. The interactions between PML nuclear bodies and small and medium size DNA viruses.
    Ryabchenko B; Šroller V; Horníková L; Lovtsov A; Forstová J; Huérfano S
    Virol J; 2023 May; 20(1):82. PubMed ID: 37127643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ND10 Component Promyelocytic Leukemia Protein Acts as an E3 Ligase for SUMOylation of the Major Immediate Early Protein IE1 of Human Cytomegalovirus.
    Reuter N; Schilling EM; Scherer M; Müller R; Stamminger T
    J Virol; 2017 May; 91(10):. PubMed ID: 28250117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of promyelocytic leukemia protein in host antiviral defense.
    Geoffroy MC; Chelbi-Alix MK
    J Interferon Cytokine Res; 2011 Jan; 31(1):145-58. PubMed ID: 21198351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Swine Promyelocytic Leukemia Isoform II Inhibits Pseudorabies Virus Infection by Suppressing Viral Gene Transcription in Promyelocytic Leukemia Nuclear Bodies.
    Yu C; Xu A; Lang Y; Qin C; Wang M; Yuan X; Sun S; Feng W; Gao C; Chen J; Zhang R; Tang J
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viral DNA Binding Protein SUMOylation Promotes PML Nuclear Body Localization Next to Viral Replication Centers.
    Stubbe M; Mai J; Paulus C; Stubbe HC; Berscheminski J; Karimi M; Hofmann S; Weber E; Hadian K; Hay R; Groitl P; Nevels M; Dobner T; Schreiner S
    mBio; 2020 Mar; 11(2):. PubMed ID: 32184235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viruses as hijackers of PML nuclear bodies.
    Möller A; Schmitz ML
    Arch Immunol Ther Exp (Warsz); 2003; 51(5):295-300. PubMed ID: 14626429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of Human Cytomegalovirus IE1 Leads to Accumulation of Mono-SUMOylated PML That Is Protected from Degradation by Herpes Simplex Virus 1 ICP0.
    Hou W; Cruz-Cosme R; Wen F; Ahn JH; Reeves I; Luo MH; Tang Q
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30258013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PML and PML nuclear bodies: implications in antiviral defence.
    Everett RD; Chelbi-Alix MK
    Biochimie; 2007; 89(6-7):819-30. PubMed ID: 17343971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear DNA helicase II is recruited to IFN-alpha-activated transcription sites at PML nuclear bodies.
    Fuchsová B; Novák P; Kafková J; Hozák P
    J Cell Biol; 2002 Aug; 158(3):463-73. PubMed ID: 12163469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional reorganization of promyelocytic leukemia nuclear bodies during BK virus infection.
    Jiang M; Entezami P; Gamez M; Stamminger T; Imperiale MJ
    mBio; 2011; 2(1):e00281-10. PubMed ID: 21304169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections.
    Tavalai N; Papior P; Rechter S; Leis M; Stamminger T
    J Virol; 2006 Aug; 80(16):8006-18. PubMed ID: 16873257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators.
    Frappier L
    Virulence; 2011; 2(1):58-62. PubMed ID: 21217204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promyelocytic leukemia nuclear bodies provide a scaffold for human polyomavirus JC replication and are disrupted after development of viral inclusions in progressive multifocal leukoencephalopathy.
    Shishido-Hara Y; Higuchi K; Ohara S; Duyckaerts C; Hauw JJ; Uchihara T
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):299-308. PubMed ID: 18379438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular proteins PML and Daxx mediate an innate antiviral defense antagonized by the adenovirus E4 ORF3 protein.
    Ullman AJ; Hearing P
    J Virol; 2008 Aug; 82(15):7325-35. PubMed ID: 18480450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PML nuclear body-residing proteins sequentially associate with HPV genome after infectious nuclear delivery.
    Guion L; Bienkowska-Haba M; DiGiuseppe S; Florin L; Sapp M
    PLoS Pathog; 2019 Feb; 15(2):e1007590. PubMed ID: 30802273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel real-time monitoring system for human cytomegalovirus-infected cells in vitro that uses a green fluorescent protein-PML-expressing cell line.
    Ueno T; Eizuru Y; Katano H; Kurata T; Sata T; Irie S; Ogawa-Goto K
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2806-13. PubMed ID: 16870775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disruption of PML-associated nuclear bodies mediated by the human cytomegalovirus major immediate early gene product.
    Wilkinson GW; Kelly C; Sinclair JH; Rickards C
    J Gen Virol; 1998 May; 79 ( Pt 5)():1233-45. PubMed ID: 9603339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SUMO Ligase Protein Inhibitor of Activated STAT1 (PIAS1) Is a Constituent Promyelocytic Leukemia Nuclear Body Protein That Contributes to the Intrinsic Antiviral Immune Response to Herpes Simplex Virus 1.
    Brown JR; Conn KL; Wasson P; Charman M; Tong L; Grant K; McFarlane S; Boutell C
    J Virol; 2016 Jul; 90(13):5939-5952. PubMed ID: 27099310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear domain 10 components upregulated via interferon during human cytomegalovirus infection potently regulate viral infection.
    Ashley CL; Glass MS; Abendroth A; McSharry BP; Slobedman B
    J Gen Virol; 2017 Jul; 98(7):1795-1805. PubMed ID: 28745271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the functional interchange between the IE1 and pp71 proteins of human cytomegalovirus and ICP0 of herpes simplex virus 1.
    Lu Y; Everett RD
    J Virol; 2015 Mar; 89(6):3062-75. PubMed ID: 25552717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.